ALKBH5 and acute myeloid leukemia: In the latter study, ALKBH5 was also found to be targetable by a bioactive peptide, downregulated its expression, promoted the decay of MLST8 and eukaryotic translation initiation factor 4e binding protein1 (EIF4EBP1) mRNAs, and in turn inhibited AML cell proliferation [99].